U.S Domestic
Available Domestic
Lab Tested
Axiolabs MOTS-c 10 mg Research Vial for Metabolic Studies
Injection · 10mg · vial
Axiolabs MOTS-c is a mitochondrial-derived peptide of 16 amino acids, studied as a metabolic modulator in skeletal muscle. Supplied as a powder in a 10 mg vial for reconstitution.
GMP-manufactured, HPLC-verified per batch with the COA on file. MOTS-c for sale with international shipping; the product page shows current availability.
Product overview
Axiolabs MOTS-c 10 mg Research Vial
Axiolabs MOTS-c is a mitochondrial-derived peptide of 16 amino acids, encoded in the mitochondrial 12S rRNA gene and studied as a metabolic modulator in skeletal muscle. Research interest is in glucose handling and the metabolic response to exercise, because the peptide level rises with physical load. No regulator has approved it, and the vial is a research material rather than a medicine; for another metabolic pathway, Tirzepatide works through incretin receptors instead.
- 10 mg of MOTS-c per vial
- Lyophilized research powder - needs a solvent
- GMP-manufactured - HPLC-verified per batch, COA on file
- International shipping with discreet plain packaging
How MOTS-c Works
The peptide is made inside mitochondria and acts as a signal, with the published work focused on glucose metabolism in skeletal muscle. Levels rise after exercise, which is why review articles call it an exercise mimetic. The human evidence is thin: a phase 2a trial listed on ClinicalTrials.gov runs daily subcutaneous dosing for twelve weeks and started in February 2026, so the results are not in. Mouse work links it to better physical performance and lower obesity. A different route to the same endpoint is Semaglutide, which acts on incretin receptors.
Reconstitution & Storage
Add bacteriostatic water down the side of the vial and swirl gently, never shake. A 10 mg vial with 1 mL gives 10 mg/mL and with 2 mL gives 5 mg/mL, so 1 mg is 10 units at the stronger mix and 20 units at the weaker one. Keep the sealed powder at 2-8 C, use a freezer for long storage, hold the solution at 2-8 C and use it within about 28 to 30 days without freezing it. A shareable control arm for a metabolic panel is NAD+.
Quality & Authenticity
Each batch is produced under GMP conditions and verified by third-party HPLC, with a Certificate of Analysis on file. International orders leave in discreet plain packaging, and the product page shows stock, which at the time of writing is out of stock.
For laboratory research only. Consult a healthcare professional before handling any peptide.
Specifications
| Trade Name | MOTS-c |
| Generic Name | Mitochondrial peptide MOTS-c |
| Manufacturer | Axiolabs |
| Dosage | 10 mg per vial |
| Package | Single vial, research powder |
| Drug Class | Mitochondrial-derived peptide, research |
| Administration | Research use after reconstitution |
| Storage | Powder cold and dry; solution 2-8 C, do not freeze |
| Prescription Status | Research use only; not for human use |
| Verification | Third-party HPLC per batch, COA on file |
| Shipping | International 4-10 days |
Stacks
For laboratory research only. Consult a healthcare professional before handling any peptide. Amounts shown are research references, not recommended human doses.
FAQ
Before you ask
Questions, answered
MOTS-c is a peptide of 16 amino acids that is encoded in the mitochondrial 12S rRNA gene rather than in the cell nucleus, which makes it part of the mitochondrial-derived peptide group. It is studied as a metabolic signal in skeletal muscle, and its level rises in response to exercise. No regulator has approved it for human use, and the vial on this page is a research material.
Published work focuses on glucose metabolism in skeletal muscle, which is why review articles call the peptide an exercise mimetic. In mice, administration has been linked to better physical performance, lower obesity and a longer healthy life. In people the evidence is still early: a phase 2a trial running daily subcutaneous dosing for twelve weeks started in February 2026 and has not reported results yet.
There is no human dose, because the peptide has never been approved and no dose-finding study in healthy people has been published. Vendor and protocol reviews collected in the project file base mention amounts of roughly 5 to 10 mg two to three times a week, with titration over about four weeks. Those are protocol reviews, not clinical findings, and they cannot be treated as a recommendation.
Add bacteriostatic water down the side of the vial and swirl gently instead of shaking. A 10 mg vial with 1 mL gives 10 mg/mL and with 2 mL gives 5 mg/mL, so 1 mg reads as 10 units on a U-100 syringe at the stronger mix and 20 units at the weaker one. Hold the solution at 2-8 C and use it within about 28 to 30 days; do not freeze it after reconstitution.
Human safety data are too thin to describe a profile. User reports mention a faster pulse or palpitations, trouble sleeping after a late injection, and redness or irritation at the injection site, none of which comes from a controlled study. There are no human data on liver effects or fluid retention either. In sport the peptide is banned at all times under class S4.4 of the WADA list, metabolic modulators.
The 10 mg vial is listed on this page and the product page shows current availability and price; at the time of writing the vial is out of stock, so check the listing for restocking rather than expecting same day dispatch. International shipping is about 45 dollars, with orders handled in one to two business days and transit of four to ten days. Each batch is GMP-manufactured and HPLC-verified with the COA on file.
Be the first to share your experience with Axiolabs MOTS-c 10 mg Research Vial for Metabolic Studies
Log in to write a reviewComplete the cycle